OTONOMY, INC.
Period
FY 2021
Revenue
$125.0K
Net Income
$-51.18M
Total Assets
$95.64M
Equity
$54.91M
Shares Out
57.15M
Op. Cash Flow
$-42.42M
Business
OTONOMY, INC. is a former operating company in Pharmaceutical Preparations, incorporated in Delaware. Securities are no longer actively traded on a major U.S. exchange.
Auto-generated from company profile
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2021 2021-12-31 | FY 2020 2020-12-31 | FY 2019 2019-12-31 | FY 2018 2018-12-31 | FY 2017 2017-12-31 |
|---|---|---|---|---|---|---|
| Product sales, net | 125,000 | 273,000 | 600,000 | 745,000 | 1 | |
| Cost of product sales | 370,000 | 1 | 912,000 | 946,000 | 3 | |
| Research and development | 35 | 28 | 33 | 32 | 43 | |
| Selling, general and administrative | 15 | 15 | 12 | 20 | 47 | |
| Total costs and operating expenses | 50 | 44 | 45 | 53 | 93 | |
| Loss from operations | −50 | −43 | −45 | −52 | −91 | |
| Interest income | 43,000 | 326,000 | 2 | 2 | 1 | |
| Interest expense | −2 | −2 | −2 | −4,000 | 0 | |
| Total other (expense) income, net | −2 | −1 | 132,000 | 2 | 1 | |
| Net loss | −51 | −45 | −45 | −50 | −90 | |
| Net loss per share, basic and diluted | −0.81 | −1.1 | −1.45 | −1.65 | −2.97 | |
| Weighted-average shares used to compute net loss per share, basic and diluted | 63 | 41 | 31 | 31 | 30 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2021 2021-12-31 | FY 2020 2020-12-31 | FY 2019 2019-12-31 | FY 2018 2018-12-31 | FY 2017 2017-12-31 |
|---|---|---|---|---|---|---|
| Cash and cash equivalents | 77 | 31 | 25 | 34 | 18 | |
| Short-term investments | — | 56 | 35 | 64 | 102 | |
| Prepaid and other current assets | 3 | 2 | 2 | 3 | 2 | |
| Total current assets | 80 | 89 | 63 | 100 | 122 | |
| Restricted cash | 702,000 | 702,000 | 701,000 | 696,000 | 1 | |
| Property and equipment, net | 2 | 3 | 4 | 4 | 5 | |
| Right-of-use assets | 13 | 14 | 15 | — | — | |
| Total assets | 96 | 106 | 83 | 105 | 128 | |
| Accounts payable | 1 | 849,000 | 1 | 1 | 961,000 | |
| Accrued expenses | 4 | 3 | 5 | 4 | 4 | |
| Accrued compensation | 3 | 4 | 3 | 3 | 3 | |
| Leases, current | 3 | 3 | 3 | — | — | |
| Total current liabilities | 12 | 11 | 12 | 7 | 8 | |
| Long-term debt, net | 16 | 15 | 15 | 15 | — | |
| Leases, net of current | 12 | 14 | 15 | — | — | |
| Total liabilities | 41 | 40 | 43 | 25 | 11 | |
| Commitments and Contingencies | — | — | 0 | — | — | |
| Preferred stock, $0.001 par value, 10,000,000 shares authorized at December 31, 2021 and 2020; no shares issued or outstanding at December 31, 2021 and 2020 | — | — | 0 | — | 0 | |
| Common stock, $0.001 par value; 200,000,000 shares authorized at December 31, 2021 and 2020; 56,732,474 and 48,318,970 shares issued and outstanding at December 31, 2021 and 2020, respectively | 57,000 | 48,000 | 31,000 | 31,000 | 31,000 | |
| Additional paid-in capital | 611 | 571 | 500 | 495 | 482 | |
| Accumulated other comprehensive income | — | 1,000 | 11,000 | −23,000 | −100,000 | |
| Accumulated deficit | −556 | −505 | −460 | −415 | −365 | |
| Total stockholders equity | 55 | 66 | 40 | 80 | 117 | |
| Total liabilities and stockholders equity | 96 | 106 | 83 | 105 | 128 |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2021 2021-12-31 | FY 2020 2020-12-31 | FY 2019 2019-12-31 | FY 2018 2018-12-31 | FY 2017 2017-12-31 |
|---|---|---|---|---|---|---|
| Net loss | −51 | −45 | −45 | −50 | −90 | |
| Depreciation | 900,000 | 1 | 1 | 1 | 1 | |
| Stock-based compensation | 7 | 6 | 5 | 12 | 14 | |
| Amortization of premiums (accretion of discounts) on short-term investments | 85,000 | −29,000 | −787,000 | −506,000 | 358,000 | |
| Amortization of debt discount | 172,000 | 191,000 | 189,000 | 0 | 0 | |
| Impairment of property and equipment | 727,000 | 0 | 0 | 0 | 400,000 | |
| Prepaid and other assets | −2 | 108,000 | 536,000 | −493,000 | 3 | |
| Accounts payable | 276,000 | −374,000 | 127,000 | 68,000 | −398,000 | |
| Accrued expenses | 1 | −2 | 2 | −166,000 | −6 | |
| Accrued compensation | −477,000 | 1 | −42,000 | −672,000 | −2 | |
| Right-of-use assets and lease liabilities, net | −168,000 | −127,000 | 32,000 | 0 | 0 | |
| Net cash used in operating activities | −42 | −39 | −37 | −38 | −75 | |
| Purchases of short-term investments | 0 | −69 | −85 | — | — | |
| Maturities of short-term investments | 55 | 49 | 114 | 143 | 200 | |
| Purchases of property and equipment | −295,000 | −134,000 | −700,000 | −496,000 | −1 | |
| Proceeds from disposition | 768,000 | 0 | — | — | — | |
| Net cash provided by (used in) investing activities | 56 | −20 | 28 | 38 | 69 | |
| Proceeds from issuance of common stock and pre-funded warrants, net of issuance costs | 32 | 64 | 0 | 0 | — | |
| Proceeds from issuance of long-term debt, net of cash issuance costs | 674,000 | 0 | 0 | 15 | 0 | |
| Proceeds from short-term debt | — | 1 | 0 | 0 | — | |
| Principal payments on short-term debt | — | −1 | 0 | 0 | — | |
| Proceeds from issuance of common stock under employee stock purchase plan | 213,000 | 270,000 | 242,000 | 303,000 | — | |
| Proceeds from exercise of stock options | 6,000 | 206,000 | 5,000 | 32,000 | — | |
| Payments of debt issuance costs | — | 0 | −52,000 | 0 | 0 | |
| Net cash provided by financing activities | 33 | 65 | 195,000 | 15 | 1 | |
| Net change in cash, cash equivalents and restricted cash | 47 | 6 | −8 | 15 | −5 | |
| Cash paid for interest | 1 | 1 | 1 | 4,000 | 0 | |
| Purchase of property and equipment in accounts payable and accrued expenses | 85,000 | 67,000 | 76,000 | 7,000 | 132,000 |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro
Frequently asked questions
What is OTONOMY, INC.'s CIK number?
OTONOMY, INC.'s SEC CIK number is 0001493566 (1493566). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find OTONOMY, INC.'s SEC filings?
All of OTONOMY, INC.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.